Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Capital Employed (2016 - 2025)

Haemonetics has reported Return on Capital Employed over the past 16 years, most recently at 13.03% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 510.0% year-over-year to 13.03%; the TTM value through Dec 2025 reached 13.03%, up 510.0%, while the annual FY2025 figure was 12.71%, 337.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 13.03% at Haemonetics, up from 12.75% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 13.03% in Q4 2025 and troughed at 2.76% in Q1 2022.
  • A 5-year average of 8.33% and a median of 8.44% in 2022 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: crashed -965bps in 2021 and later skyrocketed 575bps in 2022.
  • Year by year, Return on Capital Employed stood at 2.99% in 2021, then skyrocketed by 185bps to 8.51% in 2022, then rose by 8bps to 9.23% in 2023, then fell by -14bps to 7.93% in 2024, then skyrocketed by 64bps to 13.03% in 2025.
  • Business Quant data shows Return on Capital Employed for HAE at 13.03% in Q4 2025, 12.75% in Q3 2025, and 12.26% in Q2 2025.